• ORCID ID: 0000-0001-5033-5966

Recent relevant publications

1: Fagherazzi G, Bensoussan Y. The Imperative of Voice Data Collection in Clinical Trials. Digit Biomark. 2024 Nov 13;8(1):207-209. doi:

10.1159/000541456. PMID: 39539994; PMCID: PMC11560146.

2: Ayadi H, Elbéji A, Despotovic V, Fagherazzi G. Digital Vocal Biomarker of Smoking Status Using Ecological Audio Recordings: Results from the Colive Voice Study. Digit Biomark. 2024 Aug 28;8(1):159-170. doi: 10.1159/000540327. PMID: 39473806; PMCID: PMC11521430.

3: Fischer A, Aguayo G, Pinker I, Oustric P, Lachaise T, Wilmes P, Larché J, Benoy C, Fagherazzi G. Co-design of a voice-based app to monitor long COVID symptoms with its end-users: A mixed-method study. Digit Health. 2024 Sep 9;10:20552076241272671. doi: 10.1177/20552076241272671. PMID: 39257875; PMCID: PMC11384972.

4: Canha D, Bour C, Barraud S, Aguayo G, Fagherazzi G. The transformative role of artificial intelligence in diabetes care and research. Diabetes Metab. 2024 Sep;50(5):101565. doi: 10.1016/j.diabet.2024.101565. Epub 2024 Jul 27. PMID: 39074767.

5: Fagherazzi G et al. Heterogeneity of glycaemic phenotypes in type 1 diabetes. Diabetologia. 2024 Aug;67(8):1567-1581. doi:

10.1007/s00125-024-06179-4. Epub 2024 May 23. PMID: 38780786; PMCID: PMC11343912.

6: NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024 Mar 16;403(10431):1027-1050. doi: 10.1016/S0140-6736(23)02750-2. Epub 2024 Feb 29. PMID: 38432237; PMCID: PMC7615769.

7: NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024 Nov 23;404(10467):2077-2093. doi: 10.1016/S0140-6736(24)02317-1. Epub 2024 Nov 13. PMID: 39549716; PMCID: PMC7616842.

8: Reznik Y, Bonnemaison E, Fagherazzi G, Renard E, Hanaire H, Schaepelynck P, Mihaileanu M, Riveline JP. The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes. Diabetes Obes Metab. 2024 May;26(5):1962-1966. doi: 10.1111/dom.15462. Epub 2024 Jan 22. PMID: 38253867.

9: Julla JB, Jacquemier P, Bonnemaison E, Fagherazzi G, Hanaire H, Bellicar Schaepelynck P, Mihaileanu M, Renard E, Reznik Y, Riveline JP. Assessment of the Impact of Subcutaneous Catheter Change on Glucose Control in Patients with Type 1 Diabetes Treated by Insulin Pump in Open- and Closed-Loop Modes. Diabetes Technol Ther. 2024 Jul;26(7):442-448. doi: 10.1089/dia.2023.0568. Epub 2024 Mar 7. PMID: 38350126.

10: Ayadi H, Bour C, Fischer A, Ghoniem M, Fagherazzi G. The Long COVID experience from a patient's perspective: a clustering analysis of 27,216 Reddit posts. Front Public Health. 2023 Aug 17;11:1227807. doi: 10.3389/fpubh.2023.1227807. PMID: 37663849; PMCID: PMC10470115.

11: Fagherazzi G, Zhang L, Elbéji A, Higa E, Despotovic V, Ollert M, Aguayo GA, Nazarov PV, Fischer A. A voice-based biomarker for monitoring symptom resolution in adults with COVID-19: Findings from the prospective Predi-COVID cohort study. PLOS Digit Health. 2022 Oct 20;1(10):e0000112. doi: 10.1371/journal.pdig.0000112. PMID: 36812535; PMCID: PMC9931359.